694 related articles for article (PubMed ID: 31282646)
1. Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes.
Paul A; Viswanathan GK; Mahapatra S; Balboni G; Pacifico S; Gazit E; Segal D
ACS Chem Neurosci; 2019 Aug; 10(8):3510-3520. PubMed ID: 31282646
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone-Dopamine hybrid.
Paul A; Viswanathan GK; Huber A; Arad E; Engel H; Jelinek R; Gazit E; Segal D
FEBS J; 2021 Jul; 288(14):4267-4290. PubMed ID: 33523571
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids.
KrishnaKumar VG; Paul A; Gazit E; Segal D
Sci Rep; 2018 Jan; 8(1):71. PubMed ID: 29311706
[TBL] [Abstract][Full Text] [Related]
4. Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity.
Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D
J Alzheimers Dis; 2016; 51(1):165-78. PubMed ID: 26836184
[TBL] [Abstract][Full Text] [Related]
5. Generic inhibition of amyloidogenic proteins by two naphthoquinone-tryptophan hybrid molecules.
Scherzer-Attali R; Shaltiel-Karyo R; Adalist YH; Segal D; Gazit E
Proteins; 2012 Aug; 80(8):1962-73. PubMed ID: 22488522
[TBL] [Abstract][Full Text] [Related]
6. Key aromatic/hydrophobic amino acids controlling a cross-amyloid peptide interaction
Bakou M; Hille K; Kracklauer M; Spanopoulou A; Frost CV; Malideli E; Yan LM; Caporale A; Zacharias M; Kapurniotu A
J Biol Chem; 2017 Sep; 292(35):14587-14602. PubMed ID: 28684415
[TBL] [Abstract][Full Text] [Related]
7. Islet Amyloid Polypeptide Promotes Amyloid-Beta Aggregation by Binding-Induced Helix-Unfolding of the Amyloidogenic Core.
Ge X; Yang Y; Sun Y; Cao W; Ding F
ACS Chem Neurosci; 2018 May; 9(5):967-975. PubMed ID: 29378116
[TBL] [Abstract][Full Text] [Related]
8. Tryptophan-galactosylamine conjugates inhibit and disaggregate amyloid fibrils of Aβ42 and hIAPP peptides while reducing their toxicity.
Paul A; Frenkel-Pinter M; Escobar Alvarez D; Milordini G; Gazit E; Zacco E; Segal D
Commun Biol; 2020 Sep; 3(1):484. PubMed ID: 32879439
[TBL] [Abstract][Full Text] [Related]
9. Genistein: A Dual Inhibitor of Both Amyloid β and Human Islet Amylin Peptides.
Ren B; Liu Y; Zhang Y; Cai Y; Gong X; Chang Y; Xu L; Zheng J
ACS Chem Neurosci; 2018 May; 9(5):1215-1224. PubMed ID: 29432676
[TBL] [Abstract][Full Text] [Related]
10. Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding.
Moreno-Gonzalez I; Edwards Iii G; Salvadores N; Shahnawaz M; Diaz-Espinoza R; Soto C
Mol Psychiatry; 2017 Sep; 22(9):1327-1334. PubMed ID: 28044060
[TBL] [Abstract][Full Text] [Related]
11. Polymorphic Associations and Structures of the Cross-Seeding of Aβ1-42 and hIAPP1-37 Polypeptides.
Zhang M; Hu R; Chen H; Gong X; Zhou F; Zhang L; Zheng J
J Chem Inf Model; 2015 Aug; 55(8):1628-39. PubMed ID: 26173078
[TBL] [Abstract][Full Text] [Related]
12. Amylin and beta amyloid proteins interact to form amorphous heterocomplexes with enhanced toxicity in neuronal cells.
Bharadwaj P; Solomon T; Sahoo BR; Ignasiak K; Gaskin S; Rowles J; Verdile G; Howard MJ; Bond CS; Ramamoorthy A; Martins RN; Newsholme P
Sci Rep; 2020 Jun; 10(1):10356. PubMed ID: 32587390
[TBL] [Abstract][Full Text] [Related]
13. Novel Amylin Analogues Reduce Amyloid-β Cross-Seeding Aggregation and Neurotoxicity.
Dharmaraj GL; Arigo FD; Young KA; Martins R; Mancera RL; Bharadwaj P
J Alzheimers Dis; 2022; 87(1):373-390. PubMed ID: 35275530
[TBL] [Abstract][Full Text] [Related]
14. Catalytic Prion-Like Cross-Talk between a Key Alzheimer's Disease Tau-Fragment R3 and the Type 2 Diabetes Peptide IAPP.
Arya S; Claud SL; Cantrell KL; Bowers MT
ACS Chem Neurosci; 2019 Nov; 10(11):4757-4765. PubMed ID: 31642657
[TBL] [Abstract][Full Text] [Related]
15. Common fibrillar spines of amyloid-β and human islet amyloid polypeptide revealed by microelectron diffraction and structure-based inhibitors.
Krotee P; Griner SL; Sawaya MR; Cascio D; Rodriguez JA; Shi D; Philipp S; Murray K; Saelices L; Lee J; Seidler P; Glabe CG; Jiang L; Gonen T; Eisenberg DS
J Biol Chem; 2018 Feb; 293(8):2888-2902. PubMed ID: 29282295
[TBL] [Abstract][Full Text] [Related]
16. Tetracycline derivatives resist the assembly behavior of human islet amyloid polypeptide.
Xu J; Zhao C; Huang X; Du W
Biochimie; 2020 Jul; 174():95-106. PubMed ID: 32330570
[TBL] [Abstract][Full Text] [Related]
17. Studies on the cross-interaction between hIAPP and Aβ
Pang B; Zhuang X; Bian X; Liu S; Liu Z; Song F
J Mass Spectrom; 2020 Oct; 55(10):e4643. PubMed ID: 32893436
[TBL] [Abstract][Full Text] [Related]
18. The Inhibitory Effect of Hydroxylated Carbon Nanotubes on the Aggregation of Human Islet Amyloid Polypeptide Revealed by a Combined Computational and Experimental Study.
Mo Y; Brahmachari S; Lei J; Gilead S; Tang Y; Gazit E; Wei G
ACS Chem Neurosci; 2018 Nov; 9(11):2741-2752. PubMed ID: 29986579
[TBL] [Abstract][Full Text] [Related]
19. The Co-oligomers of Aβ42 and Human Islet Amyloid Polypeptide Exacerbate Neurotoxicity and Alzheimer-like Pathology at Cellular Level.
Deng J; Liu B; Tao Q; Luo Y; Zhu Y; Huang X; Yue F
Neuroscience; 2024 May; 547():37-55. PubMed ID: 38604526
[TBL] [Abstract][Full Text] [Related]
20. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
Dong M; Zhao W; Hu D; Ai H; Kang B
ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
